HealthTech

EdgeTech

EdgeTech Raises $3M Seed to Transform HealthTech

$3M Seed
Total Raised
Seed
Latest Round
2024
Founded
10-50
Employees
San Francisco, CA
1 min read

Quick Facts

Valuation
$100M
Latest Round Size
$3M Seed
Latest Round Date
October 2025

EdgeTech Raises $3M Seed in Latest Funding Round

EdgeTech has successfully closed a $3M Seed funding round, marking a significant milestone in the company's growth trajectory. The round was led by Accel, with participation from Thrive Capital.

Company Overview

Founded in 2024 and headquartered in San Francisco, CA, EdgeTech has established itself in the HealthTech space. Leading clinical decision support system enhancing medical accuracy with AI

With a current valuation of $100M, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $3M Seed
  • Valuation: $100M
  • Lead Investor: Accel

Future Outlook

As EdgeTech moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.

Key Investors

Accel
Venture Capital
Leading venture capital firm investing in technology companies
Thrive Capital
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

Sarah Kim
Sarah Kim
Healthcare and biotech investment analyst with expertise in Series B+ rounds and strategic partnerships.